On Friday, 89bio Inc (NASDAQ: ETNB) opened lower -3.58% from the last session, before settling in for the closing price of $9.5. Price fluctuations for ETNB have ranged from $4.16 to $11.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 32.21% over the last five years. Company’s average yearly earnings per share was noted 41.09% at the time writing. With a float of $141.33 million, this company’s outstanding shares have now reached $145.98 million.
The firm has a total of 93 workers. Let’s measure their productivity. In terms of profitability, gross margin is 42.86%, operating margin of -1920419.05%, and the pretax margin is -1837814.29%.
89bio Inc (ETNB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 89bio Inc is 3.19%, while institutional ownership is 108.52%. The most recent insider transaction that took place on Jul 15 ’25, was worth 115,280. In this transaction an insider of this company sold 10,461 shares at a rate of $11.02, taking the stock ownership to the 309,364 shares. Before that another transaction happened on Jul 15 ’25, when Company’s Officer proposed sale 10,461 for $11.02, making the entire transaction worth $115,233.
89bio Inc (ETNB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.99% during the next five years compared to 32.21% growth over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Check out the current performance indicators for 89bio Inc (ETNB). In the past quarter, the stock posted a quick ratio of 18.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.23 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Analysing the last 5-days average volume posted by the [89bio Inc, ETNB], we can find that recorded value of 1.35 million was lower than the volume posted last year of 2.12 million. As of the previous 9 days, the stock’s Stochastic %D was 19.78%.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 68.97%, which indicates a significant increase from 6.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.45 in the past 14 days, which was lower than the 0.60 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.00, while its 200-day Moving Average is $8.66. Now, the first resistance to watch is $9.37. This is followed by the second major resistance level at $9.59. The third major resistance level sits at $9.76. If the price goes on to break the first support level at $8.98, it is likely to go to the next support level at $8.81. Now, if the price goes above the second support level, the third support stands at $8.59.
89bio Inc (NASDAQ: ETNB) Key Stats
There are currently 145,984K shares outstanding in the company with a market cap of 1.34 billion. Presently, the company’s annual sales total 0 K according to its annual income of -367,080 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -71,280 K.
